Justin G. Trogdon, PhD
Articles
May 16th 2023
Shelley A. Jazowski, PhD, MPH Cleo A. Samuel-Ryals, PhD William A. Wood, MD, MPH Leah L. Zullig, PhD, MPH Justin G. Trogdon, PhD Stacie B. Dusetzina, PhD
Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.
September 20th 2012
State-Level Projections of Cancer-Related Medical Care Costs: 2010 to 2020
Justin G. Trogdon, PhD Florence K. L. Tangka, PhD Donatus U. Ekwueme, PhD Gery P. Guy Jr, PhD Isaac Nwaise, PhD Diane Orenstein, PhD
State-level estimates of the number of people treated for cancer and the average cost of their treatment by state from 2010 through 2020.
November 6th 2009
The Personal Financial Burden of Cancer for the Working-Aged Population
Eric A. Finkelstein, PhD Florence K. Tangka, PhD Justin G. Trogdon, PhD Susan A. Sabatino, MD Lisa C. Richardson, MD, MPH
Being actively treated for cancer increases the mean annual out-of-pocket medical expenditures by $1170 compared with not having cancer.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma
